XML 87 R32.htm IDEA: XBRL DOCUMENT v3.22.1
SHAREHOLDERS' DEFICIENCY (Tables)
12 Months Ended
Dec. 31, 2021
SHAREHOLDERS' DEFICIENCY  
Schedule of composition of ordinary share capital

​

​

​

​

​

​

​

​

​

​

​

​

December 31, 2020

​

December 31, 2021

​

    

Authorized

    

Issued and 
outstanding

    

Authorized

    

Issued and 
outstanding

​

​

Number of shares

Ordinary shares of no-par value *)

​

72,423,360

​

40,433,578

​

72,423,360

​

40,528,913

*)

Prior period results have been retroactively adjusted to reflect the 1: 0.905292 stock split effected on March 7, 2022. See also note 10, Shareholders’ Deficiency, for details.

Summary of the status of options and changes

​

​

​

​

​

​

​

​

​

​

​

​

Employees

​

Year ended December 31, 2021

​

​

​

​

​

​

​

​

​

​

Weighted

​

​

​

​

Weighted

​

​

​

​

average 

​

​

​

​

average

​

Aggregate 

​

remaining

​

​

Number

​

exercise

​

intrinsic

​

contractual

​

    

of options

    

price

    

value

    

life (years)

Outstanding at beginning of year

​

4,062,408

​

$

3.40

​

$

944,820

​

7.78

Granted

 

1,321,211

 

$

9.81

 

​

  

 

  

Exercised

 

(4,809)

 

$

4.42

 

​

  

 

  

Forfeited and cancelled

 

(53,238)

 

$

5.16

 

​

  

 

  

​

​

​

​

​

​

​

​

​

​

​

Outstanding at end of year

 

5,325,572

 

$

4.97

 

$

17,854,046

 

7.42

Exercisable options

 

3,233,657

 

$

3.23

 

$

14,184,527

 

6.56

​

​

​

​

​

​

​

​

​

​

​

​

Service Providers

​

Year ended December 31, 2021

​

​

​

​

​

​

​

​

​

​

Weighted

​

​

​

​

Weighted

​

​

​

​

average

​

​

​

​

average

​

Aggregate 

​

remaining

​

​

Number

​

exercise

​

intrinsic

​

contractual 

​

    

of options

    

price

    

value

    

life (years)

Outstanding at beginning of year

​

662,006

​

$

2.79

​

$

313,200

​

6.91

Granted

 

140,667

 

$

9.79

 

​

  

 

  

Exercised

 

(81,476)

 

$

1.10

 

​

  

 

  

Forfeited and cancelled

 

—

 

​

  

 

​

  

 

  

​

​

​

​

​

​

​

​

​

​

​

Outstanding at end of year

 

721,197

 

$

4.34

 

$

2,695,213

 

6.61

Exercisable options

 

580,745

 

$

3.05

 

$

2,649,873

 

5.89

Summary of the status of RSUs and changes

A summary of the status of RSUs under the Plan as of December 31, 2021 and changes during the relevant period ended on that date is presented below:

​

​

​

​

    

Number of RSU

Outstanding at beginning of year

 

—

Granted

 

1,036,850

Forfeited and cancelled

 

(5,600)

Outstanding on December 31, 2021

 

1,031,250

​

Schedule equity-based compensation expense related

​

​

​

​

​

​

​

​

​

​

​

​

​

Year ended 
December 31,

​

    

2019

    

2020

    

2021

Research and development

​

$

380

​

$

372

​

$

654

Marketing expenses

​

 

18

​

 

20

​

 

7

General and administrative

​

 

148

​

 

204

​

 

151

Total share-based compensation expense

​

$

546

​

$

596

​

$

812